{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:22:16Z","timestamp":1791030136145,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T00:00:00Z","timestamp":1221177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s11060-008-9678-2","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T13:23:51Z","timestamp":1221139431000},"page":"51-58","source":"Crossref","is-referenced-by-count":117,"title":["Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study"],"prefix":"10.1007","volume":"91","author":[{"given":"Jaishri O.","family":"Blakeley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Weingart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Supko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the New Approaches to Brain Tumor Therapy (NABTT) Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,12]]},"reference":[{"issue":"8","key":"9678_CR1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1200\/JCO.2005.04.7522","volume":"24","author":"NA Butowski","year":"2006","unstructured":"Butowski NA, Sneed PK, Chang SM (2006) Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 24(8):1273\u20131280. doi: 10.1200\/JCO.2005.04.7522","journal-title":"J Clin Oncol"},{"issue":"26","key":"9678_CR2","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1200\/JCO.2007.11.8554","volume":"25","author":"R Stupp","year":"2007","unstructured":"Stupp R, Hegi ME, Gilbert MR et al (2007) Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 25(26):4127\u20134136. doi: 10.1200\/JCO.2007.11.8554","journal-title":"J Clin Oncol"},{"issue":"8","key":"9678_CR3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1200\/JCO.2005.04.5302","volume":"24","author":"DA Reardon","year":"2006","unstructured":"Reardon DA, Rich JN, Friedman HS et al (2006) Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24(8):1253\u20131265. doi: 10.1200\/JCO.2005.04.5302","journal-title":"J Clin Oncol"},{"issue":"6","key":"9678_CR4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/CCO.0b013e3282f0313b","volume":"19","author":"MJ Brandsma Dvan den Bent","year":"2007","unstructured":"Brandsma Dvan den Bent MJ (2007) Molecular targeted therapies and chemotherapy in malignant gliomas. Curr Opin Oncol 19(6):598\u2013605","journal-title":"Curr Opin Oncol"},{"issue":"7","key":"9678_CR5","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/1535-7163.MCT-07-0047","volume":"6","author":"AM Omuro","year":"2007","unstructured":"Omuro AM, Faivre S, Raymond E (2007) Lessons learned in the development of targeted therapy for malignant gliomas. Mol Cancer Ther 6(7):1909\u20131919. doi: 10.1158\/1535-7163.MCT-07-0047","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"9678_CR6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican0794-58","volume":"271","author":"RK Jain","year":"1994","unstructured":"Jain RK (1994) Barriers to drug delivery in solid tumors. Sci Am 271(1):58\u201365","journal-title":"Sci Am"},{"issue":"22","key":"9678_CR7","first-page":"5451","volume":"55","author":"PA Netti","year":"1995","unstructured":"Netti PA, Baxter LT, Boucher Y et al (1995) Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery. Cancer Res 55(22):5451\u20135458","journal-title":"Cancer Res"},{"issue":"1","key":"9678_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1227\/01.NEU.0000097715.11966.8E","volume":"54","author":"EA Neuwelt","year":"2004","unstructured":"Neuwelt EA (2004) Mechanisms of disease: the blood-brain barrier. Neurosurgery 54(1):131\u2013140. doi: 10.1227\/01.NEU.0000097715.11966.8E discussion 141\u20132","journal-title":"Neurosurgery"},{"issue":"9","key":"9678_CR9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00003088-200645090-00002","volume":"45","author":"S Motl","year":"2006","unstructured":"Motl S, Zhuang Y, Waters CM et al (2006) Pharmacokinetic considerations in the treatment of CNS tumours. Clin Pharmacokinet 45(9):871\u2013903. doi: 10.2165\/00003088-200645090-00002","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"9678_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-006-9209-y","volume":"81","author":"ND Doolittle","year":"2007","unstructured":"Doolittle ND, Peereboom DM, Christoforidis GA et al (2007) Delivery of chemotherapy and antibodies across the blood-brain-barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the eleventh annual blood-brain barrier consortium meeting. J Neurooncol 81(1):81\u201391. doi: 10.1007\/s11060-006-9209-y","journal-title":"J Neurooncol"},{"issue":"16","key":"9678_CR11","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1200\/JCO.2006.09.9861","volume":"25","author":"LL Muldoon","year":"2007","unstructured":"Muldoon LL, Soussain C, Jahnke K et al (2007) Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol 25(16):2295\u20132305. doi: 10.1200\/JCO.2006.09.9861","journal-title":"J Clin Oncol"},{"issue":"3","key":"9678_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1211\/jpp.58.3.0001","volume":"58","author":"JA Nicolazzo","year":"2006","unstructured":"Nicolazzo JA, Charman SA, Charman WN (2006) Methods to assess drug permeability across the blood-brain barrier. J Pharm Pharmacol 58(3):281\u2013293. doi: 10.1211\/jpp.58.3.0001","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"9678_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-0173(97)00014-3","volume":"25","author":"EC Lange de","year":"1997","unstructured":"de Lange EC, Danhof M, de Boer AG et al (1997) Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier. Brain Res Brain Res Rev 25(1):27\u201349. doi: 10.1016\/S0165-0173(97)00014-3","journal-title":"Brain Res Brain Res Rev"},{"issue":"10","key":"9678_CR14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00003088-200241100-00001","volume":"41","author":"EC Lange de","year":"2002","unstructured":"de Lange EC, Danhof M (2002) Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet 41(10):691\u2013703. doi: 10.2165\/00003088-200241100-00001","journal-title":"Clin Pharmacokinet"},{"issue":"24","key":"9678_CR15","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.2174\/1381612043383476","volume":"10","author":"AC Perkins","year":"2004","unstructured":"Perkins AC, Frier M (2004) Radionuclide imaging in drug development. Curr Pharm Des 10(24):2907\u20132921. doi: 10.2174\/1381612043383476","journal-title":"Curr Pharm Des"},{"issue":"3","key":"9678_CR16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/j.1875-9114.1997.tb03057.x","volume":"17","author":"MJ Johansen","year":"1997","unstructured":"Johansen MJ, Newman RA, Madden T (1997) The use of microdialysis in pharmacokinetics and pharmacodynamics. Pharmacotherapy 17(3):464\u2013481","journal-title":"Pharmacotherapy"},{"issue":"1","key":"9678_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/meth.2000.1108","volume":"23","author":"MM Siddiqui","year":"2001","unstructured":"Siddiqui MM, Shuaib A (2001) Intracerebral microdialysis and its clinical application: a review. Methods 23(1):83\u201394. doi: 10.1006\/meth.2000.1108","journal-title":"Methods"},{"key":"9678_CR18","first-page":"46","volume":"51","author":"O Major","year":"1990","unstructured":"Major O, Shdanova T, Duffek L et al (1990) Continuous monitoring of blood-brain barrier opening to Cr51-EDTA by microdialysis following probe injury. Acta Neurochir Suppl (Wien) 51:46\u201348","journal-title":"Acta Neurochir Suppl (Wien)"},{"issue":"18","key":"9678_CR19","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2174\/1381612043384105","volume":"10","author":"U Ungerstedt","year":"2004","unstructured":"Ungerstedt U, Rostami E (2004) Microdialysis in neurointensive care. Curr Pharm Des 10(18):2145\u20132152. doi: 10.2174\/1381612043384105","journal-title":"Curr Pharm Des"},{"issue":"10","key":"9678_CR20","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1128\/AAC.42.10.2626","volume":"42","author":"T Mindermann","year":"1998","unstructured":"Mindermann T, Zimmerli W, Gratzl O (1998) Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space. Antimicrob Agents Chemother 42(10):2626\u20132629","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"9678_CR21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-004-1724-0","volume":"71","author":"AT Bergenheim","year":"2005","unstructured":"Bergenheim AT, Capala J, Roslin M et al (2005) Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study. J Neurooncol 71(3):287\u2013293. doi: 10.1007\/s11060-004-1724-0","journal-title":"J Neurooncol"},{"issue":"12","key":"9678_CR22","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1023\/A:1016239822287","volume":"12","author":"EC Lange de","year":"1995","unstructured":"de Lange EC, de Vries JD, Zurcher C et al (1995) The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain. Pharm Res 12(12):1924\u20131931. doi: 10.1023\/A:1016239822287","journal-title":"Pharm Res"},{"issue":"6","key":"9678_CR23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s002800050518","volume":"38","author":"D Devineni","year":"1996","unstructured":"Devineni D, Klein-Szanto A, Gallo JM (1996) In\u00a0vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats. Cancer Chemother Pharmacol 38(6):499\u2013507. doi: 10.1007\/s002800050518","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"9678_CR24","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1023\/A:1018945529611","volume":"16","author":"S Dukic","year":"1999","unstructured":"Dukic S, Heurtaux T, Kaltenbach ML et al (1999) Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats. Pharm Res 16(8):1219\u20131225. doi: 10.1023\/A:1018945529611","journal-title":"Pharm Res"},{"issue":"1","key":"9678_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1011973409022","volume":"15","author":"S Dukic","year":"1998","unstructured":"Dukic S, Kaltenbach ML, Gourdier B et al (1998) Determination of free extracellular levels of methotrexate by microdialysis in muscle and solid tumor of the rabbit. Pharm Res 15(1):133\u2013138. doi: 10.1023\/A:1011973409022","journal-title":"Pharm Res"},{"issue":"2","key":"9678_CR26","first-page":"317","volume":"4","author":"JP Eder Jr","year":"1998","unstructured":"Eder JP Jr, Supko JG, Lynch T et al (1998) Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion. Clin Cancer Res 4(2):317\u2013324","journal-title":"Clin Cancer Res"},{"key":"9678_CR27","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/02841860510029770","volume":"44","author":"A Comandone","year":"2005","unstructured":"Comandone A, Passera R, Boglione A, Tagini V, Ferrari SandCattel L (2005) High dose methotrexate in adult patients with osteosarcoma: Clinical and pharmacokinetic results. Acta Oncol 44:406\u2013411. doi: 10.1080\/02841860510029770","journal-title":"Acta Oncol"},{"issue":"3","key":"9678_CR28","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1148\/radiology.166.3.2829270","volume":"166","author":"F Earnest IV","year":"1988","unstructured":"Earnest FIV, Kelly PJ, Scheithauer BW et al (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166(3):823\u2013827","journal-title":"Radiology"},{"issue":"4","key":"9678_CR29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3171\/jns.2002.97.4.0794","volume":"97","author":"TR McKnight","year":"2002","unstructured":"McKnight TR, von dem Bussche MH, Vigneron DB et al (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97(4):794\u2013802","journal-title":"J Neurosurg"},{"issue":"4","key":"9678_CR30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00686291","volume":"30","author":"MG Donelli","year":"1992","unstructured":"Donelli MG, Zucchetti M D\u2019Incalci M (1992) Do anticancer agents reach the tumor target in the human brain? Cancer Chemother Pharmacol 30(4):251\u2013260. doi: 10.1007\/BF00686291","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"9678_CR31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0033-8389(22)01044-2","volume":"26","author":"JR Hesselink","year":"1988","unstructured":"Hesselink JR, Press GA (1988) MR contrast enhancement of intracranial lesions with Gd-DTPA. Radiol Clin North Am 26(4):873\u2013887","journal-title":"Radiol Clin North Am"},{"issue":"2","key":"9678_CR32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/02688690701248190","volume":"21","author":"T Flannery","year":"2007","unstructured":"Flannery T, McConnell RS, McQuaid S et al (2007) Detection of cathepsin S cysteine protease in human brain tumour microdialysates in\u00a0vivo. Br J Neurosurg 21(2):204\u2013209. doi: 10.1080\/02688690701248190","journal-title":"Br J Neurosurg"},{"issue":"12","key":"9678_CR33","first-page":"1286","volume":"41","author":"MA Rochas","year":"1991","unstructured":"Rochas MA, Tufenkji AE, Levillain P et al (1991) Protein binding of methotrexate to human albumin and serum. A first derivative spectroscopic analysis. Arzneimittelforschung 41(12):1286\u20131288","journal-title":"Arzneimittelforschung"},{"issue":"8","key":"9678_CR34","first-page":"335","volume":"34","author":"MB Maia","year":"1996","unstructured":"Maia MB, Saivin S, Chatelut E et al (1996) In\u00a0vitro and in\u00a0vivo protein binding of methotrexate assessed by microdialysis. Int J Clin Pharmacol Ther 34(8):335\u2013341","journal-title":"Int J Clin Pharmacol Ther"},{"key":"9678_CR35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s004320050305","volume":"125","author":"JE Wolff","year":"1999","unstructured":"Wolff JE, Trilling T, Molenkamp G, Egeler RM, Jurgens H (1999) Chemosensitivity of glioma cells in vitro: a metaanalysis. J Cancer Res Clin Oncol 125:481\u2013486","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9678-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-008-9678-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9678-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T18:44:37Z","timestamp":1709232277000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-008-9678-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["9678"],"URL":"https:\/\/doi.org\/10.1007\/s11060-008-9678-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,12]]}}}